SCHEMBL7576136

SCHEMBL7576136

Cc1cccc(-c2cc(CO)ccc2C#N)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AR P10275 1/20 0.47
CYP19A1 P11511 3/20 0.43
LRRK2 Q5S007 2/20 0.43
ADORA2A P29274 1/20 0.40
ADORA1 P30542 1/20 0.40
CYP11B1 P15538 1/20 0.40
CYP11B2 P19099 1/20 0.40
PDCD1 Q15116 1/20 0.39
CD274 Q9NZQ7 1/20 0.39
WNT3A P56704 1/20 0.39
KDM4E B2RXH2 3/20 0.38
CYP1A2 P05177 2/20 0.38
CYP2C9 P11712 2/20 0.38
ALDH1A1 P00352 2/20 0.38
HPGD P15428 2/20 0.38
CYP2C19 P33261 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
GALR3 O60755 1/20 0.38
GAA P10253 1/20 0.38
MAPT P10636 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7575872 0.84 CYP19A1 (0.46) ARCYP19A1LRRK2CYP11B1CYP11B2
SCHEMBL7572092 0.84 CYP19A1 (0.56) CYP19A1CYP11B1CYP11B2WNT3AKDM4E
SCHEMBL7137268 0.84 CYP19A1 (0.50) CYP19A1CYP11B1CYP11B2PDCD1CD274
SCHEMBL23606173 0.82 AR (0.55) ARLRRK2ADORA2AADORA1KDM4E
SCHEMBL2775591 0.81 MAP2K4 (0.43) ARCYP19A1CYP11B1CYP11B2PDCD1
SCHEMBL18406712 0.78 AR (0.51) ARLRRK2ADORA2AADORA1CYP11B1
SCHEMBL7570228 0.78 FFAR1 (0.39) ARCYP19A1CYP11B1CYP11B2ALDH1A1
SCHEMBL7570638 0.77 CYP19A1 (0.49) ARCYP19A1PDCD1CD274KDM4E
SCHEMBL7569910 0.77 CYP19A1 (0.43) CYP19A1CYP11B1CYP11B2PDCD1CD274
SCHEMBL7567116 0.77 NSD2 (0.40) ARCYP19A1ADORA2APDCD1CD274

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020019527-A1 Substituted phenyl farnesyltransferase inhibitors ABBOTT LABORATORIES 2002-02-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020019527-A1 Substituted phenyl farnesyltransferase inhibitors FNTA, FNTB, SLC10A1 AR 4525/4885CYP19A1 589/4885LRRK2 3748/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.